These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33098154)

  • 21. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
    Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
    Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
    Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Bowman AW; Gooch CR; Alexander LF; Desai MA; Bolan CW
    Abdom Radiol (NY); 2021 May; 46(5):2203-2218. PubMed ID: 33090256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol.
    Mukai K; Burris NS; Mahadevan VS; Foster ED; Ordovas KG; Hope MD
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):273-279. PubMed ID: 28884401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.
    Barajas RF; Hamilton BE; Schwartz D; McConnell HL; Pettersson DR; Horvath A; Szidonya L; Varallyay CG; Firkins J; Jaboin JJ; Kubicky CD; Raslan AM; Dogan A; Cetas JS; Ciporen J; Han SJ; Ambady P; Muldoon LL; Woltjer R; Rooney WD; Neuwelt EA
    Neuro Oncol; 2019 Mar; 21(4):517-526. PubMed ID: 30277536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
    McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
    Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry.
    Bruder O; Schneider S; Nothnagel D; Pilz G; Lombardi M; Sinha A; Wagner A; Dill T; Frank H; van Rossum A; Schwitter J; Nagel E; Senges J; Sabin G; Sechtem U; Mahrholdt H
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1171-6. PubMed ID: 22093267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.
    Mukundan S; Steigner ML; Hsiao LL; Malek SK; Tullius SG; Chin MS; Siedlecki AM
    Am J Kidney Dis; 2016 Jun; 67(6):984-8. PubMed ID: 26786296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
    Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
    Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
    Toth GB; Varallyay CG; Horvath A; Bashir MR; Choyke PL; Daldrup-Link HE; Dosa E; Finn JP; Gahramanov S; Harisinghani M; Macdougall I; Neuwelt A; Vasanawala SS; Ambady P; Barajas R; Cetas JS; Ciporen J; DeLoughery TJ; Doolittle ND; Fu R; Grinstead J; Guimaraes AR; Hamilton BE; Li X; McConnell HL; Muldoon LL; Nesbit G; Netto JP; Petterson D; Rooney WD; Schwartz D; Szidonya L; Neuwelt EA
    Kidney Int; 2017 Jul; 92(1):47-66. PubMed ID: 28434822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Reactions to Gadolinium-Based Contrast Agents in a Pediatric Cohort: A Retrospective Study of 16,237 Injections.
    McDonald JS; Larson NB; Kolbe AB; Hunt CH; Schmitz JJ; Kallmes DF; McDonald RJ
    AJR Am J Roentgenol; 2021 May; 216(5):1363-1369. PubMed ID: 32755216
    [No Abstract]   [Full Text] [Related]  

  • 33. Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.
    Hamilton BE; Barajas R; Nesbit GM; Fu R; Ambady P; Taylor M; Neuwelt EA
    AJR Am J Roentgenol; 2020 Dec; 215(6):1436-1442. PubMed ID: 33052739
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimation of fractional myocardial blood volume and water exchange using ferumoxytol-enhanced magnetic resonance imaging.
    Colbert CM; Thomas MA; Yan R; Radjenovic A; Finn JP; Hu P; Nguyen KL
    J Magn Reson Imaging; 2021 Jun; 53(6):1699-1709. PubMed ID: 33382176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular MRI with ferumoxytol.
    Finn JP; Nguyen KL; Han F; Zhou Z; Salusky I; Ayad I; Hu P
    Clin Radiol; 2016 Aug; 71(8):796-806. PubMed ID: 27221526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of Intrathecal Administration of Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
    Patel M; Atyani A; Salameh JP; McInnes M; Chakraborty S
    Radiology; 2020 Oct; 297(1):75-83. PubMed ID: 32720867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.
    Shah A; Neitzel E; Panda A; Fananapazir G
    Abdom Radiol (NY); 2024 Aug; 49(8):2858-2872. PubMed ID: 38561553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR; Bhatti L; Marin D; Nelson RC
    J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of ferumoxytol magnetic resonance imaging on the rhesus macaque maternal-fetal interface†.
    Nguyen SM; Wiepz GJ; Schotzko M; Simmons HA; Mejia A; Ludwig KD; Zhu A; Brunner K; Hernando D; Reeder SB; Wieben O; Johnson K; Shah D; Golos TG
    Biol Reprod; 2020 Feb; 102(2):434-444. PubMed ID: 31511859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferumoxytol magnetic resonance imaging detects joint and pleural infiltration of bone sarcomas in pediatric and young adult patients.
    Theruvath AJ; Rashidi A; Nyalakonda RR; Avedian RS; Steffner RJ; Spunt SL; Daldrup-Link HE
    Pediatr Radiol; 2021 Dec; 51(13):2521-2529. PubMed ID: 34410452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.